Niagen Bioscience Inc (NAGE)
NASDAQ: NAGE
· Real-Time Price · USD
7.32
-0.11 (-1.48%)
At close: Oct 09, 2025, 10:58 AM
-1.48% (1D)
| Bid | 5.35 |
| Market Cap | 583.83M |
| Revenue (ttm) | 116.3M |
| Net Income (ttm) | 17.73M |
| EPS (ttm) | 0.22 |
| PE Ratio (ttm) | 33.28 |
| Forward PE | 26.59 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 9.4 |
| Volume | 239,573 |
| Avg. Volume (20D) | 1,140,826 |
| Open | 7.44 |
| Previous Close | 7.43 |
| Day's Range | 7.26 - 7.49 |
| 52-Week Range | 3.18 - 14.69 |
| Beta | 2.13 |
| Ex-Dividend Date | n/a |
About NAGE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NAGE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NAGE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNiagen Bioscience Inc is scheduled to release its earnings on
Oct 30, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+2.23%
Niagen Bio shares are trading higher after reporti...
Unlock content with
Pro Subscription
2 months ago
+2.62%
Niagen Bio shares are trading higher after reporting better-than-expected Q2 financial results.
2 months ago · businesswire.com
Niagen Bioscience to Present at Canaccord Genuity's 45th Annual Growth ConferenceLOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the...
